Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Allertest10 Multihead Skin Test Device

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT07400718Not ApplicableCompleted

Head-to-Head Comparison Study Between Different FDA Registered Allergy Skin Test Applicators

Showing all 1 trials

Research Network

Common Treatments

  • Allertest10 Multihead Skin Test Device1
  • Skintestor Omni Multihead Skin Test Device1
  • Multitest Ii Multihead Skin Test Device1
  • Allertest8 Multihead Skin Test Device1

Active Sponsors

  • Qhslab Inc1
  • Alkabelló As1

Related Conditions

  • Allergy1
  • Hypersensitivity Immediate1

Activity Timeline